{"id":"W4360992337","doi":"10.1056/nejmoa2302312","title":"Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer","year":2023,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":701,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"National Institute of Environmental Health Sciences; National Cancer Institute; NRG Oncology; Merck","keywords":"Medicine; Pembrolizumab; Hazard ratio; Internal medicine; Carboplatin; Endometrial cancer; Cohort; Oncology; Placebo; Chemotherapy; Cancer; Surgery; Confidence interval; Pathology; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0006678331,0.000169894,0.0008416004,0.0009421766,0.00002444229,0.000005097859,0.0001199207,0.00007282686,0.001107525],"category_scores_gemma":[0.0008480258,0.0001031326,0.0001206238,0.001846673,0.0000545978,0.00008038591,0.00001566052,0.0003590375,0.00001493351],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002926702,"about_ca_system_score_gemma":0.0003925585,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004060926,"about_ca_topic_score_gemma":0.00007992383,"domain_scores_codex":[0.9981563,0.00005956983,0.0006417969,0.0001558585,0.0006893817,0.0002970962],"domain_scores_gemma":[0.9986799,0.0004293749,0.0002502196,0.0001371935,0.0001365055,0.0003667933],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.0308425,0.0001212329,0.02579941,0.00007302743,0.0002735459,0.001226934,0.001089294,0.0002010463,0.004663815,0.00005157021,0.006649121,0.9290085],"study_design_scores_gemma":[0.7736725,0.005712073,0.09463457,0.001074032,0.0002620324,0.0005505937,0.00023767,0.00007286675,0.001602568,0.001005371,0.1210053,0.0001703656],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9676604,0.005855833,0.00004772303,0.02191565,0.002003239,0.0002938471,0.000003826182,0.00003239467,0.002187091],"genre_scores_gemma":[0.9799421,0.009077458,0.0001451969,0.001023941,0.008061606,0.000007292384,0.000008132588,0.00002577291,0.001708526],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9288381,"threshold_uncertainty_score":0.9998056,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03607525677077003,"score_gpt":0.3494107491935854,"score_spread":0.3133354924228153,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}